MedTrace Logo

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

NCT01843920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-05-30

Study results available
· View outcomes & findings →

Summary

A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.

Conditions

  • Scleral Buckling

Interventions

DRUG

Timolol-dorzolamide (Glaucoma drops)

Patients will receive the standard post-operative drops regardless of what group you are in. The glaucoma drops will only be given to the experimental group.

DRUG

standard post-operative topical drops

Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim

Sponsors & Collaborators

  • Jason Hsu, MD

    lead OTHER

Principal Investigators

  • Jason Hsu, MD · Wills Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01843920 on ClinicalTrials.gov